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Abstract
Objective : To determine the survival of pain complaints 
at 3, 6, 9 and 12 months and the correlation between age 
at diagnosis, age of menarche, parity, stage of disease and 
post-operative medication in endometriosis patient at 
RSUPN Dr. Cipto Mangunkusumo.
Methods : This was a prospective cohort study with survival 
analysis method of 139 women of productive age with 
endometriosis who came to gynecology outpatient clinic 
in Dr. CiptoMangunkusumo Hospital from January 2015 to 
January 2017. The patients were observed at 3 months, 6 
months, 9 months and 12 months after the surgery.
Results : Survival of pain complaints at 3, 6, 9 and 12 months 
after endometriosis operation was 99.2%, 96.6%, 93% and 
88.4% respectively. There was no signifi cant correlation 
between post-operative pain survival and age of diagnosis 
(p=0.138), age of menarche (p=0.492), parity (p=0.110) and 
stage of disease (p=0.908). There was a signifi cant correlation 
between post-operative medical therapy and pain complaints 
survival. Subjects who were given medication had a risk of 
0.26 times (CI 95% 0.081-0.857) pain recurrence compared 
to those who were not.
Conclusions : Pain complaints survival were signifi cantly 
associated with post-operative medical therapy, but not 
associated with age, age of menarche, parity and stage of 
disease.
Keywords : endometriosis, postoperative medical therapy, 
postoperative pain, survival.
Abstrak
Tujuan : Mengetahui kesintasan keluhan nyeri pada 3, 6, 9 
dan 12 bulan dan hubungan antara usia saat diagnosis, usia 
menarke, paritas, stadium penyakit dan terapi medisinalis 
pascapembedahan pada pasien endometriosis di RSUPN Dr. 
CiptoMangunkusumo.
Metode : Penelitian kohort prospektif pada 139 perempuan 
usia produktif dengan metode analisis kesintasan pada 
pasien endometriosis yang dating ke poliklinik ginekologi 
RSUPN Cipto Mangunkusumo pada bulan Januari 2015 
hingga Januari 2017. Pasien kemudian diobservasi pada 
bulan ke 3, 6, 9 dan 12 setelah operasi.
Hasil : Kesintasan keluhan nyeri pada bulan ke 3, 6, 9 dan 
12 berturut-turut adalah 99,2%, 96,6%, 93% dan 88,4%. 
Tidak ada hubungan yang bermakna antara kesintasan nyeri 
pascapembedahan dengan usia saat diagnosis (p=0,138), 
usia saat menarke (p=0,492), paritas (p=0,110) dan stadium 
penyakit (p=0,908). Terdapat hubungan yang bermakna 
antara terapi medisinalis  pascapembedahan dan kesintasan 
keluhan nyeri. Subyek yang mendapatkan terapi medisinalis 
pascapembedahan memiliki risiko 0,26 kali mengalami 
kekambuhan nyeri dibandingkan dengan yang tidak.
Kesimpulan : Kesintasan keluhan nyeri memilki hubungan 
yang bermakna dengan terapi medisinalis pascapembedahan 
namun tidak memiliki hubungan dengan usia saat diagnosis, 
usia menarke, paritasdan stadium penyakit.
Kata kunci : fendometriosis, kesintasan, nyeripascapembe-
dahan, terapi medisinalis pascapembedahan.
INTRODUCTION
Endometriosis is defi ned as abnormal 
implantation of endometrial tissue outside the 
uterine cavity. This ectopic tissue may lead to 
chronic infl ammation process that depends on 
estrogen hormone.1-7 Endometriosis is found 
in up to 176 million people all over the world. 
It affects around 5-10% women of reproductive 
age.5,7,8This disease is one of the leading causes of 
pain complaints; which includes dysmenorrhea, 
dyspareunia, chronic pelvic pain, dysuria and 
dyschezia.4 In Dr. Cipto Mangunkusumo Hospital, 
most endometriosis patients came with the 
complaint of pelvic pain (82.5%), followed by 
dysmenorrhea (81%), low back pain (32.5%), 
278 Sumapraja, and Nuryadi
Indones J
Obstet Gynecol
In this study, the age of subject sranges from 
17-49 years old with the median of 40 years old. 
Most subjects (87.1%) are 30 years and above. 
One hundred and thirty-fi ve subjects (97.1%) 
had menarche at the age of 11 or more. Most 
subjects (66 patients) were nullipara, 23 subjects 
(16.5%) were primipara, 29 subjects (20.9%) had 
2 parity, 19 subjects (13.7%) 3parity and only 2 
subjects had 4 parity.
Table 1. Characteristics of Postoperative Endometriosis 
Patients in Cipto Mangunkusumo from January 2015 to 
January 2017
Characteristics Description (n=139)
Age (years)
Age category
Age of menarche
Parity
Parity category
Stage of disease
Stage of disease 
category
Medical therapy
Post-operative medical 
therapy
Pain after surgery
<30
≥30
<11
≥11
0
1
2
3
4
0
1-2
≥3
Minimal
Mild
Moderate
Severe
Minimal andmild
Moderate and 
severe
No
Yes
No medicinal 
therapy
Progestin
GnRH agonist
Progestin + GnRH 
agonist
COC
COC + progestin
Did not 
recur (censor)
Recur (event)
40 (17 – 49)
18 (12.9%)
121 (87.1%)
4 (2.9%)
135 (97.1%)
66 (47.5%)
23 (16.5%)
29 (20.9%)
19 (13.7%)
2 (1.4%)
66 (47.5%)
53 (38.1%)
20 (14.4%)
1 (0.7%)
24 (17.8%)
47 (37.8%)
67 (48.2%)
25 (18%)
114 (82%)
91 (65.5%)
48 (34.5%)
91 (65.5%)
28 (20.1%)
11 (7.9%)
2 (1.4%) 
6 (4.3%)
1 (0.7%)
126 (90.6%)
13 (9.4%)
dyspareunia (20,9%) and dyschezia (4.6%). 
These pain complaints lead to low quality of life; 
therefore,treatment is required.7,9,10
There are two modalities in treating 
endometriosis patients which are conservative 
and surgical therapy. Until today, the treatment 
of choice to treat endometriosis is laparoscopy. 
This treatment has several purposes such as to 
lessen the pain, recurrence rate and to maintain 
fertility.11,12
Endometriosis has a high recurrence rate of 
21.5%, 46.7% and 55.4% at the second, fi fth and 
seventh year after surgery.13 A study 23 studies, 
the recurrence rate of endometriosis after surgery 
is as high as 40-50% at the fi fth year.14,15This 
study also stated that the risk factors of this high 
recurrence include age when diagnosed, stage of 
disease and history of previous treatment.
These data imply that pain recurrence in 
endometriosis patients is an essential aspect. 
Therefore, it is important to know what factors 
could affect pain survival. Considering that, we 
are interested to know the recurrence rate of 
pain in endometriosis patients through survival 
analysis and its correlating factors in Dr. Cipto 
Mangunkusumo Hospital.
METHODS
This research was a prospective cohort study. 
Subjects were women 18-49 years old who came 
to Gynecology Outpatient Clinic from January 
2015 to January 2017. A total of 154 patients 
obtained consecutively who were diagnosed 
with endometriosis underwent surgery in Dr. 
CiptoMangunkusumo Hospital at that time. 
Only 139 out of 154 patients metthe inclusion 
criteria of this research. Inclusion criteria were 
endometriosis patients who had a psychosocial 
activity limitation, use of analgesic medication, 
and visual analogue scale (VAS) of 4 or more. The 
VAS was 4 or more on dysmenorrhea, dyspareunia, 
pelvic pain, dysuria or dyschezia symptoms with 
a minimum of once at the measurement period. 
Exclusion criteria were patients who had a history 
of abdominal surgery (except appendectomy), 
who had other diseases than endometriosis 
which could lead to pelvic pain, diagnosed with 
neurotic disease and/or psychiatric diseases and 
had a history of tubectomy.
Data were analyzed using SPSS®softwarefor 
IOS version 22.0. The survival rate of pain 
complaints was analyzed using Kaplan-Meier 
analysis. All variables meet the proportional 
hazard assumption, therefore the analysis was 
done using cox regression. Patients were followed 
up to 12 months.
RESULT
Subjects who were under 30 years old and 30 
years above had the pain survival rate at 12 
months follow-up of 63% and 87%, respectively. 
However, the log-rank test analysis showed there 
was no signifi cant association between pain 
survival and the age category (p=0.152). In this 
study, subjects who had menarche on the age 
of 11 years old and above had the pain survival 
rate of 86% after 12 months follow-up. Below 
11 years old, the pain survival was 50% after 12 
months follow up, while 11 years oldhas pain 
Time of pain complaints (months)
Figure 1. Kaplan Meier Curve of Overall Pain Survival 
in Endometriosis Patients
Endometriosis degree of patients in this study 
was assessed into four stage. One subject (0.7%) 
had minimal disease, 24 subjects (17.8%) had 
mild disease, 47 subjects (37.8%) had moderate 
disease and 67 patients (48.2%) had severe 
disease. Forty-eight subjects (34.5%) were given 
medical therapy after the surgery. Most of them 
(20.1%) were given progestin medication. After 
a 3 months regular follow-up up to a year, 126 
patients (90.6%) stated the pain did not recur.
Survival Rate
The pain survival rate were acknowledged every 
three months. On the third months, the pain 
survival rate were 99.2%. However this percentage 
were decreased to 96.6% after 6-month follow-
up and 93% after 9 months follow up. After 12 
months of follow-up, the pain survival rate was 
88.4%. From the Kaplan-Meier curve, the survival 
rate decreased over time. However, this research 
did not reach the median time because the 
observation is limited to 12 months.
survival for 86% after 12 months follow-up, This 
study also analyzed the association between age 
of menarche and pain survival and it is found 
that there was no signifi cant association between 
both variables (p=0.286). Subjects with 0, 1-2, 
and 3 or more parity had the pain survival rate 
after 12 months follow-up of 83%, 93% and 
68%, respectively. However, both groups were 
statistically insignifi cant, with the p value= 0.061. 
At 3 months follow up, subjects with 0, 1-2, and 3 
or more parity had an almost similar percentage 
of survival 98%, 100%, and 100% respectively, 
however, signifi cant decrease after six months 
follow up were subjects with three or more parity 
(87%).
In this study, subjects with a minimal-mild 
stage of endometriosis experienced pain survival 
of 90% and subjects with moderate-severe stage's 
pain survival were 83%. Nevertheless, this result 
is statistically insignifi cant (p=0.908).
The pain survival rate of patients who received 
postoperative medical therapy was started from 
100% on 3 months follow up to  73% after 12 
months follow-up, and those who did not receive 
had the pain survival rate was started from 99% 
on the fi rst 3-month follow-up to  91%. From 
the analysis, the post-operative medical therapy 
category and pain survival had no signifi cant 
association.
Variables were also analyzed using bivariate 
analysis to fi nd the hazard ratio. The hazard ratio 
(HR) of age when diagnosed, age of menarche, 
parity, stage of the disease and post-operative 
medical therapy were 2.46, 2.85, 0.44 and 0.03, 
0.92 and 0.26, respectively. Variables who had the 
p-value < 0.25, which were age, age of menarche, 
parity and post-operative medical therapy, were 
then included in the multivariate analysis. From 
the multivariate analysis, it was found that post-
operative medical therapy had the p-value of 
0.027 and HR of 0.26 (CI 95% 0.081-0.857).
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Table 2. Multivariate Analysis Result
Variables HR
Model 1 Model 2 Model 3 Model 4 (last)
Age category
Age of menarche category
Parity category
Post-operative medical therapy
3.83
-
1.89
0.24
2.39
-
-
0.27
3.31
2.22
1.92
0.25
3.31
2.22
1.92
0.25
DISCUSSION
From 139 subjects, 13 subjects had censor (loss to 
follow up). Overall, the pain survival rate reduces 
over time from 99.2% at three months to 88.4% 
at 12 months. The median time of pain survival 
was 24 months. Therefore, this study needed a 
longer follow-up time.16
Pain Survival and Age when Diagnosed
Pain survival in postoperative endometriosis 
patients with the age < 30 years old when 
diagnosed at 3, 6, 9 and 12 months were 100%, 
100%, 92% and 63%. While the group of age 30 
and above had the pain survival of 98%, 96%, 
92% and 87%. This showed that pain recurrence 
was found more in patients age 30 and above. 
Though statistically insignifi cant, this variable 
was included in the multivariate analysis because 
it was clinically signifi cant. However, at the third 
model, this variable did not affect the pain 
complaints.
This result was similar that age and pain 
survival is statistically insignifi cant but patients 
with younger age (29,9±5,4 years old vs 32.6±6.1 
years old) had clinically signifi cant pain survival 
and recurrence of endometriosis with the HR = 
0.935 (CI 0.895-0.977).16,17 Endometriosis patients 
who were diagnosed at a younger age were 
linked with lesser estrogen and therefore may 
reduce the recurrence rate. The low survival rate 
of 63% at subjects <30 years old may be due to 
limited number of samples in this category.
Pain Survival and Age of Menarche
Patients who had menarche at the age of <11 
years old had pain survival at 3, 6, 9 and 12 
months of 100%, 100%, 100% and 50%. While the 
other group had the pain survival of 99%, 96%, 
93% and 86%. However, this variable is clinically 
insignifi cant after the Log rank test. This variable 
was included in the multivariate analysis because 
its p value=0.315 but at the end of the analysis, 
this variable showed no effect in pain complaints.
This result showed that patients who had 
menarche at a younger age had a higher risk of 
pain complaints recurrence. This was supported 
by other literature that stated patients who had 
menarche at an earlier age is at higher risk of pain 
recurrence in endometriosis.16
Pain Survival and Parity
Subjects with 0-1 parity had the highest pain 
survival rate at 3, 6, 9 and 12 months among 
the group, which were 100%, 100%, 98% and 
93%. From the log-rank test, parity was not 
signifi cantly associated with pain survival. 
However, this variable was found to be clinically 
signifi cant and was included in the multivariate 
analysis. This result was different from 
several studies that found pregnancy before 
endometriosis surgery as a protective factor of 
pain survival with the OR=0.759 (p<0.05).12,18-
20Infertility was found to have a linked with more 
prolonged estrogen exposure and therefore 
could trigger the occurrence of endometriosis.
In contrast, pregnancy could cause regression of 
endometriosis lesion.21,22
Pain Survival and Stage of Disease
In this study, the stage of disease was categorized 
into minimal-mild and moderate-severe. Patients 
with minimal-mild disease had the pain survival 
after 3, 6, 9 and 12 months of 95%, 95%, 90% and 
90%. While patients with the moderate-severe 
disease had the pain survival of 100%, 97%, 94% 
and 83%. From the log-rank test, this variable 
was found to be statistically unassociated with 
the pain survival rate. Bivariate analysis showed 
that this variable in clinically insignifi cant, so this 
variable was not included in the multivariate 
analysis.
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From other literature, high recurrence rate 
was found in subjects with moderate to severe 
stage of endometriosis. Besides the stage, the 
surgery technique was also associated with the 
recurrence rate. Conservative operations could 
lead to progressive growing of endometriosis 
and therefore subjects can experience chronic 
pelvic pain.13,16,23-27
Pain Survival and Medical Therapy
Forty-eight subjects received medical therapy 
after the surgical procedure in this study. From 
the 48 subjects, 20.1% received progestin, 7.9% 
received Gn-RH agonist, 1.4% received progestin 
and Gn-RH agonist, 4.3% received combined oral 
contraceptives (COC); 0.7% received COC and 
progestin. The pain survival of subjects receiving 
medical therapy was 100%, 93%, 86% and 73% 
at 3, 6, 9 and 12 months follow-up. From the 
bivariate analysis, this variable was found to 
have a signifi cant association with pain survival 
(HR=0.26, CI 95% 0.08-0.86; p=0.027).
From a systematic review, though still 
inconsistent, it was found that hormonal therapy 
suppression after surgery compared to surgery 
alone reduced pain complaints after 12 months.28 
Some studies showed that patients who were 
treated with laparoscopic excision and cyclic oral 
contraceptives (such as desogestrel, gestodene 
and dianogest) had signifi cant reduction of pain 
than those treated with laparoscopic excision 
alone. Progestin prevented implantation and 
endometriosis growth by inhibiting the expression 
of metalloproteinase matrix and angiogenesis 
thus reducing infl ammation.29-31
Besides progestin, COC could also be used. 
COC worked by reducing the frequency of 
menstrual period, inducing endometriosis 
to become atrophy, reducing prostaglandin 
production that plays a role in pain and reducing 
cell proliferation.29,32 Gn-RH agonist is another 
treatment method of endometriosis;however, it 
should not be used for longer than 6 months due 
to its effect of estrogen defi cit.33
CONCLUSIONS
In conclusion, the 3, 6, 9 and 12 months follow-
up of post-operative endometriosis patients 
showed a pain survival of 99.2%, 96.6%, 93% and 
88.4%, respectively. Age, age of menarche, parity 
and stage of the disease have no signifi cant 
association with the pain survival of post-operative 
endometriosis patients. However, postoperative 
medical therapy was signifi cantly associated with 
reduction of pain. Longer study and randomized 
controlled trial (RCT) study is needed to reduce 
selection bias and indication bias.
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